Mechanistic insights into the role of huc-mscs in treating acute liver failure

FHS
May 16, 2024
5:25 pm

Acute liver failure (ALF) is a life-threatening clinical problem with limited treatment options. Administration of human umbilical cord mesenchymal stem cells (hUC-MSCs) may be a promising approach for ALF.

Canadian Cannabis Sales Rebound In July

Statistics Canada released July retail sales for the country, with cannabis sales increasing from the June levels, up 1.6% to C$440.7 million. On a per-day basis, sales

September 20, 2024

Wearables and machine learning predict five-year fall risk in Parkinson’s patients

Wearable sensor data combined with machine learning predicts fall risk in Parkinson’s patients, enhancing preventive care and clinical outcomes over five years.

December 10, 2024

MindBio Therapeutics Scientists Present Landmark Women’s Health Trials, Company to Release Phase 2A Depression Trial Secondary Data This Month | Psychedelic Invest

VANCOUVER – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6), (the ‘Company’ or ‘MindBio’), a clinical stage biopharma company pioneering microdosing treatments for mental health conditions showcases Dr Rachael Sumner,

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.